Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sandra Klein

Showing results (1-10 of 94) with videos related to

Pageof 10
Sort By:
The AAPS Journal|May 12, 2010
The use of biorelevant dissolution media to forecast the in vivo performance of a drugSandra Klein
AAPS Pharmscitech|July 27, 2019
Advancements in Dissolution Testing of Oral and Non-oral FormulationsSandra Klein
Journal of Pharmacy & Pharmaceutical Sciences : a Publication of the Canadian Society for Pharmaceutical Sciences, Societe Canadienne Des Sciences Pharmaceutiques|August 17, 2017
Development and Validation of a Robust and Efficient HPLC Method for the Simultaneous Quantification of Levodopa, Carbidopa, Benserazide and Entacapone in Complex MatricesErik Wollmer, Sandra Klein
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|December 12, 2018
Individualized in vitro and in silico methods for predicting in vivo performance of enteric-coated tablets containing a narrow therapeutic index drugFrank Karkossa, Sandra Klein
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|September 23, 2022
Patient-specific in vitro drug release testing coupled with in silico PBPK modeling to forecast the in vivo performance of oral extended-release levodopa formulations in Parkinson's disease patientsErik Wollmer, Sandra Klein
Die Pharmazie|May 30, 2026
Comparative <i>In Vitro</i> Release Profiling of Brand and Generic Metoprolol Extended-Release Formulations in the Context of Product SwitchingFrank Karkossa, Sandra Klein
Pharmaceutics|October 19, 2019
In Vitro Methods for Evaluating Drug Release of Vaginal Ring Formulations-A Critical ReviewKatharina Tietz, Sandra Klein
International Journal of Pharmaceutics|September 6, 2017
A review of patient-specific gastrointestinal parameters as a platform for developing in vitro models for predicting the in vivo performance of oral dosage forms in patients with Parkinson's diseaseErik Wollmer, Sandra Klein
The Journal of Pharmacy and Pharmacology|July 14, 2017
Assessing the influence of media composition and ionic strength on drug release from commercial immediate-release and enteric-coated aspirin tabletsFrank Karkossa, Sandra Klein
The Journal of Pharmacy and Pharmacology|June 13, 2012
Dissolution testing of oral modified-release dosage formsGrzegorz Garbacz, Sandra Klein
Pageof 10

Showing results (1-10 of 94) with videos related to

Sort By:
Pageof 10
The AAPS Journal|May 12, 2010
The use of biorelevant dissolution media to forecast the in vivo performance of a drugSandra Klein
AAPS Pharmscitech|July 27, 2019
Advancements in Dissolution Testing of Oral and Non-oral FormulationsSandra Klein
Journal of Pharmacy & Pharmaceutical Sciences : a Publication of the Canadian Society for Pharmaceutical Sciences, Societe Canadienne Des Sciences Pharmaceutiques|August 17, 2017
Development and Validation of a Robust and Efficient HPLC Method for the Simultaneous Quantification of Levodopa, Carbidopa, Benserazide and Entacapone in Complex MatricesErik Wollmer, Sandra Klein
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|December 12, 2018
Individualized in vitro and in silico methods for predicting in vivo performance of enteric-coated tablets containing a narrow therapeutic index drugFrank Karkossa, Sandra Klein
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|September 23, 2022
Patient-specific in vitro drug release testing coupled with in silico PBPK modeling to forecast the in vivo performance of oral extended-release levodopa formulations in Parkinson's disease patientsErik Wollmer, Sandra Klein
Die Pharmazie|May 30, 2026
Comparative <i>In Vitro</i> Release Profiling of Brand and Generic Metoprolol Extended-Release Formulations in the Context of Product SwitchingFrank Karkossa, Sandra Klein
Pharmaceutics|October 19, 2019
In Vitro Methods for Evaluating Drug Release of Vaginal Ring Formulations-A Critical ReviewKatharina Tietz, Sandra Klein
International Journal of Pharmaceutics|September 6, 2017
A review of patient-specific gastrointestinal parameters as a platform for developing in vitro models for predicting the in vivo performance of oral dosage forms in patients with Parkinson's diseaseErik Wollmer, Sandra Klein
The Journal of Pharmacy and Pharmacology|July 14, 2017
Assessing the influence of media composition and ionic strength on drug release from commercial immediate-release and enteric-coated aspirin tabletsFrank Karkossa, Sandra Klein
The Journal of Pharmacy and Pharmacology|June 13, 2012
Dissolution testing of oral modified-release dosage formsGrzegorz Garbacz, Sandra Klein
Pageof 10